HealthCare Global Enterprises Limited

470.1

INR
+9.50(+2.06%)
As of November 14, 2024 10:00:00 AM

HealthCare Global Enterprises Limited Share Price Information

24 hour Low and High

Low: 459
High: 474.55

All time High

474.65

Price Change 1h

+₹9.65 +2.10%

Price Change 1d

+₹9.65 +2.10%

Price Change 1w

+₹2.50 +0.53%

HealthCare Global Enterprises Limited Market Information

Exchange

NSE

Market Cap

6230.60 Cr

About HealthCare Global Enterprises Limited Share

HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and outpatients treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. In addition, the company offers cancer diagnostic services; combining laboratory services; and research and development, and clinical research to enhance cancer diagnosis and prognosis. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.

Sector

Healthcare

Medical Care Facilities

Employees

about

6150

CEO

Mr. Meghraj Arvindrao Gore

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Healthcare Global Enterprises | The doctor entrepreneurs | Company Business News
  • HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
  • KKR in exclusive talks to acquire cancer hospital chain HCG from CVC Capital
  • HealthCare Global Enterprises acquires Andhra-based MGCHRI for Rs 414 cr
  • Healthcare Global Enterprises: HCG shares in focus on report buyout funds eyeing controlling stake

FAQs

HealthCare Global Enterprises Limited

470.1

INR
+9.50(+2.06%)
As of November 14, 2024 10:00:00 AM

HealthCare Global Enterprises Limited Share Price Information

24 hour Low and High

Low: 459
High: 474.55

All time High

474.65

Price Change 1h

+₹9.65 +2.10%

Price Change 1d

+₹9.65 +2.10%

Price Change 1w

+₹2.50 +0.53%

HealthCare Global Enterprises Limited Market Information

Exchange

NSE

Market Cap

6230.60 Cr

About HealthCare Global Enterprises Limited Share

HealthCare Global Enterprises Limited, together with its subsidiaries, provides medical and healthcare services focusing on cancer and fertility in India and internationally. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand that provides inpatient and outpatients treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. In addition, the company offers cancer diagnostic services; combining laboratory services; and research and development, and clinical research to enhance cancer diagnosis and prognosis. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India.

Sector

Healthcare

Medical Care Facilities

Employees

about

6150

CEO

Mr. Meghraj Arvindrao Gore

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Healthcare Global Enterprises | The doctor entrepreneurs | Company Business News
  • HealthCare Global Enterprises Limited Just Missed Earnings - But Analysts Have Updated Their Models
  • KKR in exclusive talks to acquire cancer hospital chain HCG from CVC Capital
  • HealthCare Global Enterprises acquires Andhra-based MGCHRI for Rs 414 cr
  • Healthcare Global Enterprises: HCG shares in focus on report buyout funds eyeing controlling stake

FAQs